Liang Lj, Hu Cx, Wen Yx, Geng Xw, Chen T, Gu Gq, Wang L, Xia Yy, Liu Y, Fei Jy, Dong J, Zhao Fh, Ahongjiang Y, Hui Ky, Jiang Xd
Purpose
This study aimed to investigate the potential systemic antitumor effects of stereotactic ablative
radiotherapy (SABR) and apatinib (a novel vascular endothelial growth factor receptor
2 inhibitor) via reversing the immunosuppressive tumor microenvironment...